Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2

Human Immunology

Volumn 69, Issue 3, 2008, Pages 158-164

  Pandey, Janardan P ^a   Luo, Yuqun ^b   Elston, Robert C ^b   Wu, Yuping ^c   Philp, Frances Hite ^d   Astemborski, Jacquie ^d   Thomas, David L ^d   Netski, Dale M ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLEVELAND STATE UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GM and KM allotypes; Hepatitis C virus; Humoral immunity; IgG antibodies; Immunoglobulin; Proteins E1 and E2

Indexed keywords

EPITOPE; GLYCOPROTEIN E1; GLYCOPROTEIN E2; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN;

ADULT; AFRICAN AMERICAN; ALLOTYPE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; FEMALE; GENETIC MARKER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; ALLELES; ANTIBODY FORMATION; EPITOPES; FEMALE; HAPLOTYPES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN GM ALLOTYPES; IMMUNOGLOBULIN KM ALLOTYPES; MALE; MIDDLE AGED; PHENOTYPE; SEROLOGIC TESTS; VIRAL ENVELOPE PROTEINS;

EID: 41549144235     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.01.019     Document Type: Article

References (49)

1. Pandey J.P., Astemborski J., and Thomas D.L. Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus. J Virol 78 (2004) 4561
2. Vejbaesya S., Tanwandee T., and Pandey J.P. Immunoglobulin GM and KM genotypes in hepatitis C virus infection. J Med Virol 73 (2004) 384
3. Muratori P., Sutherland S.E., Muratori L., Granito A., Guidi M., Pappas G., et al. Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. J Virol 80 (2006) 5097
4. Namboodiri A.M., Budkowska A., Nietert P.J., and Pandey J.P. Fcγ receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes. Mol Immunol 44 (2007) 3805
5. Pandey J.P., Montes-Cano M.A., Aguilar-Reina J., and Gonzalez-Escribano M.F. Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus. Clin Exp Immunol 150 (2007) 518
6. Biggar R.J., Pandey J.P., Henle W., Nkrumah F.K., and Levine P.H. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients. Int J Cancer 33 (1984) 577
7. Hyöty H., Pandey J.P., Lehtinen M., Kulomaa P., and Leinikki P. Immunoglobulin allotypes and virus antibodies in Finnish type 1 diabetic patients. Exp Clin Immunogenet 5 (1988) 52
8. Pandey J.P. Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Clin Exp Rheumatol 22 (2004) S35
9. Netski D.M., Mosbruger T., Depla E., Maertens G., Ray S.C., Hamilton R.G., et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 41 (2005) 667
10. Chen M., Sallberg M., Sonnerborg A., Weiland O., Mattsson L., Jin L., et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 116 (1999) 135
11. Lal R.B., Buckner C., Khabbaz R.F., Kaplan J.E., Reyes G., Hadlock K., et al. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-1. Clin Immunol Immunopathol 67 (1993) 40
12. Skvaril F. IgG subclasses in viral infections. Monogr Allerg 19 (1986) 134
13. Sundqvist V.A., Linde A., Kurth R., Werner A., Helm E.B., Popovic M., et al. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis 153 (1986) 970
14. Torres M., Fernández-Fuentes N., Fiser A., and Casadevall A. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J Biol Chem 282 (2007) 13917
15. Pestka J.M., Zeisel M.B., Blaser E., Schurmann P., Bartosch B., Cosset F.L., et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci USA 104 (2007) 6025
16. Bartosch B., and Cosset F.L. Cell entry of hepatitis C virus. Virology 348 (2006) 1
17. Zhang P., Wu C.G., Mihalik K., Virata-Theimer M.L., Yu M.Y., Alter H.J., et al. Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma. Proc Natl Acad Sci U S A 104 (2007) 8449
18. Nattermann J., Schneiders A.M., Leifeld L., Langhans B., Schulz M., Inchauspé G., et al. Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). J Hepatol 42 (2005) 499
19. Vlahov D., Anthony J.C., Muñoz A., Margolick J., Celentano D.D., Solomon L., et al. The ALIVE Study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods. J Drug Issues 21 (1991) 759
20. Thomas D.L., Astemborski J., Rai R.M., Anania F.A., Schaeffer M., Galai N., et al. The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 284 (2000) 450
21. Vyas G.N., Fudenberg H.H., Pretty H.M., and Gold E.R. A new rapid method for genetic typing of human immunoglobulins. J Immunol 100 (1968) 274
22. Schanfield M.S., and van Loghem E. Human immunoglobulin allotypes. In: Weir D.M. (Ed). Handbook of Experimental Immunology (Volume 3): Genetics and Molecular Immunology (1986), Blackwell, Boston 94.1
23. Pandey J.P. Genetics of immunoglobulins. In: Virella G. (Ed). Medical Immunology (2007), Marcel Dekker, New York 73
24. Dard P., Lefranc M.P., Osipova L., and Sanchez-Mazas A. DNA sequence variability of IGHG3 alleles associated to the main G3m haplotypes in human populations. Eur J Hum Genet 9 (2001) 765
25. Grubb R. Advances in human immunoglobulin allotypes. Exp Clin Immunogenet 12 (1995) 191
26. Martin S.W., and Goodnow C.C. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol 3 (2002) 182
27. Wakabayashi C., Adachi T., Wienands J., and Tsubata T. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science 298 (2002) 2392
28. Morahan G., Berek C., and Miller J.F.A.P. An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature 301 (1983) 720
29. H1 constant region domain modulate antigen binding affinity of antibodies?. J Clin Invest 98 (1996) 2235
30. Cooper L.J.N., Robertson D., Granzow R., and Greenspan N.S. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol Immunol 31 (1994) 577
31. McLean G.R., Torres M., Elguezabal N., Nakouzi A., and Casadevall A. Isotype can affect the fine specificity of an antibody for a polysaccharide antigen. J Immunol 169 (2002) 1379
32. Hu Y.W., Rocheleau L., Larke B., Chui L., Lee B., Ma M., et al. Immunoglobulin mimicry by hepatitis C virus envelope protein E2. Virology 332 (2005) 538
33. Moxley G., and Gibbs R.S. Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment. Genomics 13 (1992) 104
34. Czerwinski M., Siemaszko D., Siegel D.L., and Spitalnik S.L. Only selected light chains combine with a given heavy chain to confer specificity for a model glycopeptide antigen. J Immunol 160 (1998) 4406
35. Primi D., Drapier A.M., and Cazenave P.A. Highly preferential VH-VL pairing in normal B cells results in antigen-independent selection of the available repertoire. J Immunol 138 (1987) 1607
36. Nimmerjahn F., and Ravetch J.V. Antibodies, Fc receptors and cancer. Curr Opin Immunol 19 (2007) 239
37. van der Pol W., and van de Winkel J.G. IgG receptor polymorphisms: Risk factors for disease. Immunogenetics 48 (1998) 222
38. Stockmeyer B., Valerius T., Repp R., Heijnen I.A., Buhring H.J., Deo Y.M., et al. Preclinical studies with FcγR bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res 57 (1997) 696
39. Pandey J.P. Genetic polymorphism of Fc. Science 311 (2006) 1376
40. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872
41. Ray S.C., Wang Y.M., Laeyendecker O., Ticehurst J.R., Villano S.A., and Thomas D.L. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. J Virol 73 (1999) 2938
42. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288 (2000) 339
43. Ray S.C., Mao Q., Lanford R.E., Bassett S., Laeyendecker O., Wang Y.M., and Thomas D.L. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 74 (2000) 3058
44. Booth J.C., Kumar U., Webster D., Monjardino J., and Thomas H.C. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27 (1998) 223
45. Cox A.L., Mosbruger T., Lauer G.M., Pardoll D., Thomas D.L., and Ray S.C. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42 (2005) 104
46. Cox A.L., Mosbruger T., Mao Q., Liu Z., Wang X.H., Yang H.C., et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201 (2005) 1741
47. Legrand L., Rivat-Perran L., Huttin C., and Dausset J. HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum Immunol 4 (1982) 1
48. Wachsmuth R.R., Pandey J.P., Fedrick J.A., Nishimura Y., and Sasazuki T. Interactive effect of Gm and Km allotypes on cellular immune responses to streptococcal cell wall antigen. Exp Clin Immunogenet 4 (1987) 163
49. Schmidt W., Königstedt B., Zipprich B., Scheibe E., and Nilius R. Immunoglobulin allotypes and immunoreactivity in chronic liver disease. Hepatogastroenterology 34 (1987) 206